I do feel like I'm mainly benefitting from the immune modulation but it's really very hard to tell and if the sore throat is from ebv then I'm surprised the taf isn't hitting it harder. Or maybe it is.
My understanding is that we get a flair because, as viral DNA transcription to RNA is inhibited, the viral proteins that inhibit our immune response are decreased, increasing immune recognition and destruction of virally infected cells, which further exposes the immune system to viral particles, in turn increasing the immune response even more. Nonetheless, at some point, the flair should stop and the symptoms should decrease to below baseline as a much larger percentage of viruses are pushed into their dormant phases.
I guess there is some information out there that TAF can also cause a TH2 to TH1 shift, although I was not able to find it myself. I suppose that in HIV treatment, it may cause an increase in TH1 simply by working in conjunction with other HIV anti-virials to increase the CD4 count.
I wonder how much of a leap of faith with TAF because we only have in vitro studies on its effectiveness against EBV. Knowing that TAF does get into our cells, I don't see why the in vitro wouldn't translate well into in vivo, which is why think it is worth trying.
I am sure I read recently that Dr Chia advises patients to take Inosine to draw out entereoviruses to expose them so that certain drugs can then get rid of them. Off topic but I am wondering if these drugs are enough by themselves.
I am not sure what Chia means by "drawing the virus out so that certain drugs can get rid of them". We can't get rid of a virus by causing it to replicate and then using an antiviral that inhibits replication because that only prevents the new virus from forming, but the "mother template" remains untouched. I just may not be understanding the context or the drugs involved.
As we know, with viruses that establish latency in cells, unfortunately, all antivirals can do is keep them in the latent phase. This is because their mechanisms only work on actively dividing viruses, but don't get rid of the viral reservoir.
The exception to this would be the immune activating medications because they may increase immune recognition of infected cells and facilitate the actual destruction of the cell and the viral DNA/RNA it is hosting. I think of Inosine and Oxymatrine in this category. This is also why people are interested in interferons, because they can strongly activate viral recognition by the Th1 side of immunity. Of course, that can come with scary side-effects from immune over activation. Apparently, peginterferon lambda is only active in the mucus membranes, which has generated great interest.